A detailed history of Jump Financial, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 152,609 shares of PCRX stock, worth $2.97 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
152,609
Previous 12,300 1140.72%
Holding current value
$2.97 Million
Previous $351,000 554.7%
% of portfolio
0.05%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $28.46 $1.64 Million - $3.99 Million
140,309 Added 1140.72%
152,609 $2.3 Million
Q2 2024

Aug 14, 2024

SELL
$25.5 - $31.51 $713,209 - $881,303
-27,969 Reduced 69.46%
12,300 $351,000
Q1 2024

May 13, 2024

BUY
$27.7 - $35.48 $26,841 - $34,380
969 Added 2.47%
40,269 $1.18 Million
Q4 2023

Oct 21, 2024

SELL
$26.32 - $34.31 $515,161 - $671,549
-19,573 Reduced 33.25%
39,300 $1.33 Million
Q4 2023

Feb 07, 2024

SELL
$26.32 - $34.31 $515,161 - $671,549
-19,573 Reduced 33.25%
39,300 $1.33 Million
Q3 2023

Oct 21, 2024

BUY
$30.68 - $40.09 $1.45 Million - $1.89 Million
47,173 Added 403.19%
58,873 $1.81 Million
Q3 2023

Nov 07, 2023

BUY
$30.68 - $40.09 $1.45 Million - $1.89 Million
47,173 Added 403.19%
58,873 $1.81 Million
Q2 2023

Oct 21, 2024

SELL
$36.12 - $47.5 $21,672 - $28,500
-600 Reduced 4.88%
11,700 $468,000
Q2 2023

Aug 07, 2023

BUY
$36.12 - $47.5 $422,603 - $555,750
11,700 New
11,700 $468,000
Q4 2022

Feb 13, 2023

BUY
$38.19 - $57.45 $1.35 Million - $2.03 Million
35,382 New
35,382 $1.37 Million
Q1 2022

May 12, 2022

SELL
$60.03 - $76.49 $387,973 - $494,354
-6,463 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$47.97 - $62.21 $310,030 - $402,063
6,463 New
6,463 $389,000
Q3 2021

Nov 12, 2021

SELL
$54.64 - $61.3 $1.35 Million - $1.51 Million
-24,685 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$59.18 - $69.99 $1.46 Million - $1.73 Million
24,685 New
24,685 $1.5 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.